日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Androgen receptor-induced lncRNA SOX2-OT promotes triple-negative breast cancer tumorigenesis via targeting miR-320a-5p-CCR5 axis.

雄激素受体诱导的lncRNA SOX2-OT通过靶向miR-320a-5p-CCR5轴促进三阴性乳腺癌的肿瘤发生

Hu Yixuan, Bian Jin, Chen Weiwei, Shi Junfeng, Wei Xiaowei, Du Yueyao, Zhang Wenwen

The role of autophagy in regulating metabolism in the tumor microenvironment

自噬在肿瘤微环境代谢调控中的作用

Zhang, Panpan; Cheng, Shanshan; Sheng, Xiaonan; Dai, Huijuan; He, Kang; Du, Yueyao

Identification of Genes Predicting Poor Response of Trastuzumab in Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer

鉴定预测人表皮生长因子受体2阳性乳腺癌对曲妥珠单抗疗效不佳的基因

Dong, Xinrui; Dai, Huijuan; Sun, Aijun; Yu, Zhenfeng; Du, Yueyao

Serum miR-222-3p as a Double-Edged Sword in Predicting Efficacy and Trastuzumab-Induced Cardiotoxicity for HER2-Positive Breast Cancer Patients Receiving Neoadjuvant Target Therapy

血清 miR-222-3p 在预测接受新辅助靶向治疗的 HER2 阳性乳腺癌患者的疗效和曲妥珠单抗诱导的心脏毒性方面是一把双刃剑

Zhang, Shan; Wang, Yaohui; Wang, Yan; Peng, Jing; Yuan, Chenwei; Zhou, Liheng; Xu, Shuguang; Lin, Yanping; Du, Yueyao; Yang, Fan; Zhang, Jie; Dai, Huijuan; Yin, Wenjin; Lu, Jinsong

Effects of serum from breast cancer surgery patients receiving perioperative dexmedetomidine on breast cancer cell malignancy: A prospective randomized controlled trial

围手术期接受右美托咪定治疗的乳腺癌手术患者血清对乳腺癌细胞恶性程度的影响:一项前瞻性随机对照试验

Liu, Yan; Sun, Jiaxin; Wu, Tong; Lu, Xiaoying; Du, Yueyao; Duan, Hongwei; Yu, Weifeng; Su, Diansan; Lu, Jinsong; Tian, Jie

Polymorphisms in microRNA let-7 binding sites of the HIF1AN and CLDN12 genes can predict pathologic complete response to taxane- and platinum-based neoadjuvant chemotherapy in breast cancer

HIF1AN 和 CLDN12 基因中 microRNA let-7 结合位点的多态性可以预测乳腺癌患者对紫杉烷类和铂类新辅助化疗的病理完全缓解。

Du, Yueyao; Zhou, Liheng; Lin, Yanping; Yin, Kai; Yin, Wenjin; Lu, Jinsong

Downregulated circulating microRNAs after surgery: potential noninvasive biomarkers for diagnosis and prognosis of early breast cancer

手术后循环microRNA表达下调:早期乳腺癌诊断和预后的潜在非侵入性生物标志物

Wang, Yaohui; Yin, Wenjin; Lin, Yanping; Yin, Kai; Zhou, Liheng; Du, Yueyao; Yan, Tingting; Lu, Jinsong

A single-nucleotide polymorphism of the beta 2-adrenergic receptor gene can predict pathological complete response to taxane- and platinum-based neoadjuvant chemotherapy in breast cancer

β2-肾上腺素能受体基因的单核苷酸多态性可以预测乳腺癌患者对紫杉烷类和铂类新辅助化疗的病理完全缓解情况。

Du, Yueyao; Yan, Tingting; Zhou, Liheng; Yin, Wenjin; Lu, Jinsong

Clinical significance of quantitative HER2 gene amplification as related to its predictive value in breast cancer patients in neoadjuvant setting

HER2基因定量扩增的临床意义及其在乳腺癌新辅助治疗患者中的预测价值

Wu, Ziping; Xu, Shuguang; Zhou, Liheng; Yin, Wenjin; Lin, Yanpin; Du, Yueyao; Wang, Yaohui; Jiang, Yiwei; Yin, Kai; Zhang, Jie; Lu, Jinsong

Weekly paclitaxel and cisplatin as neoadjuvant chemotherapy with locally advanced breast cancer: a prospective, single arm, phase II study

每周一次紫杉醇和顺铂作为局部晚期乳腺癌新辅助化疗:一项前瞻性、单臂、II期研究

Zhou, Liheng; Xu, Shuguang; Yin, Wenjin; Lin, Yanpin; Du, Yueyao; Jiang, Yiwei; Wang, Yaohui; Zhang, Jie; Wu, Ziping; Lu, Jinsong